Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy IMV stock | $1.56

Learn how to easily invest in IMV stock.

IMV Inc is a biotechnology business based in the US. IMV shares (IMV) are listed on the NASDAQ and all prices are listed in US Dollars. IMV employs 77 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in IMV

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IMV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

IMV stock price (NASDAQ: IMV)

Use our graph to track the performance of IMV stocks over time.

IMV shares at a glance

Information last updated 2021-10-23.
Latest market close$1.56
52-week range$1.31 - $4.57
50-day moving average $1.66
200-day moving average $2.06
Wall St. target price$9.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.44

Buy IMV shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy IMV stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IMV price performance over time

Historical closes compared with the close of $1.56 from 2021-10-25

1 week (2021-10-19) -1.27%
1 month (2021-09-24) -9.30%
3 months (2021-07-26) -23.90%
6 months (2021-04-26) -45.26%
1 year (2020-10-26) -50.48%
2 years (2019-10-25) -47.36%
3 years (2018-10-26) 5.55
5 years (2016-10-26) 179.42%

IMV financials

Revenue TTM $2,421
Gross profit TTM $-26,602,000
Return on assets TTM -67.91%
Return on equity TTM -166.38%
Profit margin 0%
Book value $0.29
Market capitalisation $124.2 million

TTM: trailing 12 months

Shorting IMV shares

There are currently 646,949 IMV shares held short by investors – that's known as IMV's "short interest". This figure is 43.1% down from 1.1 million last month.

There are a few different ways that this level of interest in shorting IMV shares can be evaluated.

IMV's "short interest ratio" (SIR)

IMV's "short interest ratio" (SIR) is the quantity of IMV shares currently shorted divided by the average quantity of IMV shares traded daily (recently around 333478.86597938). IMV's SIR currently stands at 1.94. In other words for every 100,000 IMV shares traded daily on the market, roughly 1940 shares are currently held short.

However IMV's short interest can also be evaluated against the total number of IMV shares, or, against the total number of tradable IMV shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IMV's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 IMV shares in existence, roughly 10 shares are currently held short) or 0.0086% of the tradable shares (for every 100,000 tradable IMV shares, roughly 9 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IMV.

Find out more about how you can short IMV stock.

IMV share dividends

We're not expecting IMV to pay a dividend over the next 12 months.

Have IMV's shares ever split?

IMV's shares were split on a 312:1000 basis on 9 May 2018. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 312 shares. This wouldn't directly have changed the overall worth of your IMV shares – just the quantity. However, indirectly, the new 220.5% higher share price could have impacted the market appetite for IMV shares which in turn could have impacted IMV's share price.

IMV share price volatility

Over the last 12 months, IMV's shares have ranged in value from as little as $1.31 up to $4.57. A popular way to gauge a stock's volatility is its "beta".

IMV.US volatility(beta: 1.91)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IMV's is 1.91. This would suggest that IMV's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

IMV overview

IMV Inc. , a biopharmaceutical company, focuses on the development of cancer immunotherapies and vaccines against infectious diseases using its DPX delivery technology platform. The company's lead drug candidate includes maveropepimut-S (DPX-Survivac), a T cell therapy, which is in three Phase II clinical trials across 6 different cancer indications with and without Merck's Keytruda; and Phase II clinical trials for the treatment of ovarian cancer, and recurrent and refractory diffuse large B cell lymphoma. It is also developing DPX-COVID-19, a second-generation vaccine against severe acute respiratory syndrome coronavirus 2; and DPX-RSV, a vaccine candidate, which has completed Phase I clinical trials for the treatment of respiratory syncytial virus strain A, as well as DPX-SurMAGE for the treatment of bladder cancer and DPX-BRAF to treat melanoma patients. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018.

Frequently asked questions

What percentage of IMV is owned by insiders or institutions?
Currently 0.612% of IMV shares are held by insiders and 18.52% by institutions.
How many people work for IMV?
Latest data suggests 77 work at IMV.
When does the fiscal year end for IMV?
IMV's fiscal year ends in December.
Where is IMV based?
IMV's address is: 130 Eileen Stubbs Avenue, Dartmouth, NS, Canada, B3B 2C4
What is IMV's ISIN number?
IMV's international securities identification number is: CA44974L1031
What is IMV's CUSIP number?
IMV's Committee on Uniform Securities Identification Procedures number is: 44974L103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site